World's most exclusive M-RNA corona vaccine prepared in India

48

The whole world is watching India's self-reliance on corona vaccination. After getting the vaccine at the lowest cost, now the world's most special vaccine is also being prepared in India with the M RNA technology.


From temperature to price, this vaccine will be different than most other countries. The vaccine is being prepared after a long search and day-to-day hard work by Indian scientists. So far, two types of vaccines exist in the world, based on mRNA technology.


American pharmaceutical company Pfizer has developed the vaccine using this technique, which is very important to keep it at -70 ° C temperature. The price per dose of this vaccine is about Rs 1431. A similar vaccine has been developed by the Morgana company, which can be kept at a temperature of 2 to 8 degrees Celsius, but the cost of this vaccine can be around Rs 2715 per dose.


That is, a person can cost at least five thousand rupees, but the mRNA technology developed in India with which the vaccine has been developed will be safe only in the temperature of 2 to 8 degrees Celsius and its price is also around 200 to 300 rupees per dose. May be around. However, this is an estimate of prices.

Officials associated with the Ministry of Health say that they sincerely hope that this vaccine will not be available at a higher price.

According to the information, scientists of Genoa Biopharmaceuticals Limited and DBT Ministry of Government of India have prepared it together. The vaccine is currently undergoing human trials under the first phase. Union Health Secretary Rajesh Bhushan said that the second phase of the vaccine is expected to be tested in the coming March.

NITI Aayog member Dr. VK Paul says that the M RNA vaccine has come up with low temperature so far. In such a situation, it is very difficult for India to take storage facilities at such a low temperature, but Indian scientists have prepared a completely different vaccine to understand the needs of India, which can be kept safe even at high temperatures. This is a big success.

Dr. Renu Swaroop, Secretary, DBT, and Chairman of BIRAC said that this vaccine is completely different in the world. This is a big success for India. This M-RNA platform supported by DBT uses advances in nucleic acid vaccines and delivery systems. This vaccine based on nanotechnology has been quite effective in animal testing.

mRNA vaccine is different from others

A senior DBT scientist said that the mRNA vaccine is different. It contains a special part of the genetic material of the coronavirus. This is called messenger RNA or mRNA.

On entering the body, this mRNA starts directing our cells to make the virus-like protein with which the real coronavirus attacks. Due to this, the body starts increasing immunity.

Both types of vaccines are being prepared in India

Scientists say that research is being carried out in the field of immunology with regard to DNA and mRNA technology. India is the country with the help of Coronavirus, where scientists have worked on both the techniques and prepared the vaccine. Zydus Cadila's vaccine is DNA based. While the M RNA vaccine has also been developed. Both vaccines have come under human trials.